Metraipolis › archive › dc_2a5e5ed2e7ea
Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial — Europe PMC PMID:41109919
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41109919
- DOI
- 10.1038/s41591-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T05:20:29.938Z
- SHA-256 of the archived text
a7d696daf4687fe259f44703d9a8d0d415d5dcd58dc79d113894e2fd3350dcd3- Stable URL of this page
https://metraipolis.com/documento/dc_2a5e5ed2e7ea
How to cite
Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial — Europe PMC PMID:41109919 — Europe PMC (en), https://europepmc.org/article/MED/41109919 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2a5e5ed2e7ea (Metraipolis archive dc_2a5e5ed2e7ea, sha256 a7d696daf4687fe259f44703d9a8d0d415d5dcd58dc79d113894e2fd3350dcd3)
BibTeX
@misc{dc2a5e5ed2e7ea,
title = {Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial — Europe PMC PMID:41109919},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41109919},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2a5e5ed2e7ea; sha256 a7d696daf4687fe259f44703d9a8d0d415d5dcd58dc79d113894e2fd3350dcd3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41109919. Agents can read the archived copy with the MCP tool read_document.